miR-30a radiosensitizes non-small cell lung cancer by targeting ATF1 that is involved in the phosphorylation of ATM

Abstract

Increasing number of studies report that microRNAs play important roles in radiosensitization. miR-30a has been proved to perform many functions in the development and treatment of cancer, and it is downregulated in non-small cell lung cancer (NSCLC) tissues and cells. This study was conducted to understand if miR-30a plays a role in the radiosensitivity of NSCLC cells. Radiosensitivity was examed by colony survival assay and tumor volume changing in vitro and in vivo, respectively. Bioinformatic analysis and luciferase reporter assays were used to distinguish the candidate target of miR-30a. qRT-PCR and western blotting were carried out to detect the relative expression of mRNAs and proteins. Cell cycle and cell apoptosis were determined by flow cytometry. Our results illustrated miR-30a could increase the radiosensitivity of NSCLC, especially in A549 cell line. In vivo experiment also showed the potential radiosensitizing possibility of miR-30a. Further exploration validated that miR-30a was directly targeting activating transcription factor 1 (ATF1). In studying the ataxia-telangiectasia mutated (ATM) associated effects on cell radiosensitivity, we found that miR-30a could reduce radiation induced G2/M cell cycle arrest and may also affect radiation induced apoptosis. Together, our results demonstrated that miR-30a may modulate the radiosensitivity of NSCLC through reducing the function of ATF1 in phosphorylation of ATM and have potential therapeutic value.

miR-149 suppresses human non-small cell lung cancer growth and metastasis by inhibiting the FOXM1/cyclin�D1/MMP2 axis

“…miR-502e was found to serve as a tumor suppressor and inhibit NSCLC cell growth, invasion and migration by targeting Zbtb7a partly depending on the Wnt signaling pathway (13). However, miR-30a reduced radiation-induced G2/M cell cycle arrest and may also affect radiation-induced apoptosis by targeting ATF1 (14). This accumulating evidence shows that miRNAs are promising biomarkers and therapeutic targets in NSCLC.…”

MicroRNA‑145 inhibits migration and induces apoptosis in human non‑small cell lung cancer cells through regulation of the EGFR/PI3K/AKT signaling pathway

“…The recent identification of a novel class of non-proteincoding miRNA, with no open reading frame, has confirmed that the genomic complexity of cancer far exceeds original expectations (15). miRNAs are a type of small endogenous non-coding RNA with no open reading frame, which are 20-25 nucleotides in length.…”

Circulating microRNA-34 family low expression correlates with poor prognosis in patients with non-small cell lung cancer

“…Accumulating evidences disclose that several miRNAs act as important biomarkers for the diagnosis and prognosis of various cancers, such as NSCLC, pancreatic cancer and colorectal cancer (9)(10)(11).…”